glp-1 receptor agonist dry eye Agonists Shown to Reduce AMD Risk, Progression in Type 2 Diabetes Patients As the use of GLP-1

Carris NW, Taylor JR, Gums JG

This is really exciting for us to see just further evidence of the benefits of these medications beyond weight loss. 19 Myth : Losing weight is the biggest benefit of GLP-1 medicines

Underlining the role of PCSK2 in liberation of glucagon via proglucagon processing, PCSK2-deficient mice are slightly hypoglycemic upon fasting, have a reduced rise in blood glucose following intraperitoneal glucose administration, display impaired processing of Gcg in the -cells, and develop -cell hyperplasia [154,155]

In the intestine, DPP-4 is highly expressed in the enterocyte brush border and in endothelial cells [191]

Importantly, their influence extends to skeletal muscle, where GLP-1 RAs promote glucose uptake via the AMP-activated protein kinase pathway, increase vascular blood flow, and mitigate glucotoxicity, thereby supporting muscle protein synthesis and inhibiting catabolic pathways [14, 15]